Results 161 to 170 of about 2,652,994 (308)
Repositioning renal denervation in resistant hypertension: evidence-based insights, stratified decision-making, and implementation pathways. [PDF]
Li M, Yang D, Cheng X, Wei Q, Zhang D.
europepmc +1 more source
Aim Many women take medications during pregnancy. However, the risk to the fetus from most medications is uncertain. Congenital anomalies are one of the leading causes of infant death and contribute to long‐term disability. Signal detection methods can be used to systematically identify possible medication–anomaly associations that require further ...
Hannah Johnson +22 more
wiley +1 more source
Factors related to the risk of developing chronic kidney disease in resistant hypertensive patients: a cross-sectional study. [PDF]
Guimarães AO +3 more
europepmc +1 more source
Renal Arteriography in Hypertension [PDF]
openaire +2 more sources
Prior glucocorticoid exposure is associated with modestly increased vancomycin clearance in hospitalized children, partly mediated by renal function and inflammation and may contribute to subtherapeutic early drug exposure. Abstract Introduction Augmented renal clearance (ARC) can lead to subtherapeutic vancomycin exposure in children.
Kouki Tomari +6 more
wiley +1 more source
Uncontrolled Hypertension Leading to the Diagnosis of Renal Cell Carcinoma: A Case Report. [PDF]
Loja J +4 more
europepmc +1 more source
Aims Pulmonary arterial hypertension (PAH) is a syndrome characterized by elevated pulmonary artery pressure. We developed a population pharmacokinetic (PPK) model using combined plasma drug concentration data from Japanese paediatric (<15 years) and adult (≥15 years) patients with PAH to investigate the pharmacokinetic characteristics of PAH ...
Motoyasu Miura +13 more
wiley +1 more source
KNG-1, HSPG and Robo4 reflect hypertension-driven subclinical renal alterations and provide incremental diagnostic value in type 2 diabetic nephropathy. [PDF]
Hamed HI +3 more
europepmc +1 more source
Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu +5 more
wiley +1 more source

